Lv31
340 积分 2024-05-10 加入
PCSK9-directed therapies: an update
4小时前
待确认
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
1个月前
已完结
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association
1个月前
已完结
Reader response: Lipid levels and the risk of hemorrhagic stroke among women
1个月前
已完结
Author response: Lipid levels and the risk of hemorrhagic stroke among women
1个月前
已完结
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
1个月前
已完结
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
1个月前
已完结
2024 ESC Guidelines for the management of chronic coronary syndromes
2个月前
已完结
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
2个月前
已完结
An up-to-date review of emerging biologic therapies for hypercholesterolemia
2个月前
已完结
皖公网安备34019202002308
